Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy

Area of Science:

• Biochemistry
• Bone Metabolism
• Genetics

Background:

• Gaucher disease involves enzyme deficiency leading to skeletal complications.
• Splenectomized patients experience more severe bone abnormalities.
• The effect of enzyme replacement therapy (ERT) on bone health in Gaucher disease is not well understood.

Purpose of the Study:

• To investigate the synergistic effects of vitamin D supplementation and ERT on bone density in splenectomized Gaucher patients.
• To assess the impact of calcitriol and glucocerebrosidase infusions on bone mineral density and other skeletal markers.

Main Methods:

• A 24-month randomized study involving 29 splenectomized Gaucher patients.
• Three groups received varying combinations of calcitriol (vitamin D) and ceredase/cerezyme (ERT).
• Bone mineral density was measured using quantitative CT; skeletal MRI and biochemical markers were also assessed.

Main Results:

• Overall bone density declined in the lumbar spine; no significant differences were observed between treatment groups.
• Calcitriol showed no significant effect on bone density, but fat fraction increased and skeletal MRI scores improved.
• Biochemical markers of bone turnover increased, while hemoglobin, platelet counts, and liver volume improved.

Conclusions:

• ERT, alone or with calcitriol, did not repair bone composition in splenectomized adult Gaucher patients.
• Trabecular bone density may not be an adequate marker for assessing the efficacy of treatments for skeletal involvement in Gaucher disease.
• Further research is needed to identify effective therapeutic strategies for bone abnormalities in Gaucher disease.